PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
11-Jun-2020 UK's Vaccines Manufacturing and Innovation Centre Signs First Industry Partnership with Oxford Biomedica The Vaccines Manufacturing and Innovation Centre
11-Jun-2020 The RSA Group reveals new global brand The RSA Group
11-Jun-2020 Here’s What Industry Insiders Say About Patient Access Solutions Market markets and markets
11-Jun-2020 LILLY’S IXEKIZUMAB (TALTZ®) RECEIVES EU MARKETING AUTHORISATION FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS (axSpA) Eli Lilly and Company
11-Jun-2020 Significant growth opportunities in the High Content Screening Market markets and markets
11-Jun-2020 Roxadustat Demonstrates Non-Inferiority to Darbepoetin in Phase 3 DOLOMITES Study of Anemia in Non-Dialysis-Dependent Adult Patients with Chronic Kidney Disease Astellas Pharma Inc
11-Jun-2020 Roxadustat Demonstrates Non-Inferiority to Darbepoetin in Phase 3 DOLOMITES Study of Anemia in Non-Dialysis-Dependent Adult Patients with Chronic Kidney Disease Astellas Pharma Inc
11-Jun-2020 Anti-TNF therapies could treat patients with COVID-19-related acute respiratory distress, says GlobalData GlobalData Press Office
11-Jun-2020 Fujifilm to invest 100 billion yen [807 million EUR] to expand its large scale biologics production facility in Denmark Fujifilm
11-Jun-2020 Herbert Smith Freehills advises Achilles Vaccines in record seed financing for biotech sector Herbert Smith Freehills
11-Jun-2020 Izana Bioscience’s drug namilumab announced in major UK COVID-19 drugs trial Izana Bioscience
11-Jun-2020 Helsinn Group supports Conquer Cancer, the ASCO Foundation’s COVID Impacts Cancer fund Helsinn Group
11-Jun-2020 Genmab and AbbVie Announce Broad Oncology Collaboration Genmab
11-Jun-2020 Orgenesis announces anti-viral “BioShield” program designed to potentially increase preparedness, rapidly address virus spread and protect against future outbreaks such as COVID-19 Orgenesis
11-Jun-2020 Pierre Fabre receives European Commission Marketing Authorisation for BRAFTOVI® (encorafenib) in combination with Erbitux® (cetuximab) for the treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC) who have received prior systemic therapy Pierre Fabre
11-Jun-2020 Sanofi to present growth opportunities and development strategy for Dupixent® (dupilumab) in type 2 inflammatory diseases Dupixent
11-Jun-2020 Faron selected for €2.5 million grant from European Innovation Council Accelerator pilot for MATINS study acceleration Faron Pharmaceuticals Oy
11-Jun-2020 N95 Mask Market due to Pandemic is Likely to Create Short-term Opportunities for Manufacturers Regal Intelligence
11-Jun-2020 Ethos, a new company, launched to re-define compliance training in a digital age Ethos Pharmaceutical Ethics and Compliance Limited
11-Jun-2020 Quell Therapeutics strengthens its Board with the appointments of Dr Dhaval Patel and Sir Robert Lechler and hires Dr Natalie Belmonte as SVP Research & Translation Quell Therapeutics